0
Deep & Emerging Tech·October 13, 2026·1 min read

Science Corporation implants its vision-restoring chip in its first Stargardt disease patient

Share

A PRIMA-based vision chip in a Stargardt patient is a step toward practical BCIs that start in the periphery and move inward. Health systems and medtech operators should expect a pipeline of niche neuroprosthetics before generalized interfaces—and plan for data, reimbursement, and surgical training ahead of broader rollout.